|
|
|
|
|
|
|
|
|
|
Efficacy and Safety of Every-2-Week Darbepoetin Alfa in Patients with Anemia of Cancer: A Controlled, Randomized, Open-Label Phase II Trial -- Charu et al. 12 (6): 727 -- The Oncologist
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
ovarian cancer
Ovarian Cancer Awareness (teal)
ovarian cancer
Ovarian Cancer
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.